Metrion Biosciences, a specialist ion channel CRO and drug discovery company, has secured £3.5 million (about US$3,19 million) in new equity financing, including £2.5m from lead investor Maven Capital Partners and £1 million from existing investor, Gresham House Ventures. The funding will be used to further expand Metrion’s laboratories in Cambridge, UK, invest in specialist […]

ProBioGen’s Transposase binds to specific epigenetic histone marks characteristic for highly active genome regions. Omitting the plasmid backbone, multiple transposable elements carrying the transgene cassette are specifically inserted resulting in highly stable and high expressing clones.

Bayer and the Broad Institute of MIT and Harvard have renewed their research alliance, adding five years to a 10-year collaboration that has already yielded three clinical oncology candidates. This research collaboration is aimed at identifying cancer targets and exploring novel therapeutic approaches in oncology with the goal of bringing more medicines to patients.

MIMETAS, a leader in human 3D disease modelling, and Yamaha Motor Co., a developer of the Cell Handler, have singed a strategic joint marketing agreement aimed at advancing therapeutic development using human-relevant models throughout the early drug development pipeline. The collaboration combines MIMETAS’ comprehensive disease modelling and assay development expertise with Yamaha Motor’s state-of-the-art Cell […]